These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14724177)

  • 1. NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK.
    Zhang JY; Green CL; Tao S; Khavari PA
    Genes Dev; 2004 Jan; 18(1):17-22. PubMed ID: 14724177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment.
    Alcamo E; Mizgerd JP; Horwitz BH; Bronson R; Beg AA; Scott M; Doerschuk CM; Hynes RO; Baltimore D
    J Immunol; 2001 Aug; 167(3):1592-600. PubMed ID: 11466381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice.
    Rosenfeld ME; Prichard L; Shiojiri N; Fausto N
    Am J Pathol; 2000 Mar; 156(3):997-1007. PubMed ID: 10702415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms.
    Gugasyan R; Voss A; Varigos G; Thomas T; Grumont RJ; Kaur P; Grigoriadis G; Gerondakis S
    Mol Cell Biol; 2004 Jul; 24(13):5733-45. PubMed ID: 15199130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
    Lizzul PF; Aphale A; Malaviya R; Sun Y; Masud S; Dombrovskiy V; Gottlieb AB
    J Invest Dermatol; 2005 Jun; 124(6):1275-83. PubMed ID: 15955104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal RelA specifically restricts contact allergen-induced inflammation and apoptosis in skin.
    Kumari S; Herzberg B; Pofahl R; Krieg T; Haase I
    J Invest Dermatol; 2014 Oct; 134(10):2541-2550. PubMed ID: 24739902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of developing B cell survival by RelA-containing NF-kappa B complexes.
    Prendes M; Zheng Y; Beg AA
    J Immunol; 2003 Oct; 171(8):3963-9. PubMed ID: 14530314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB inhibition in keratinocytes causes RIPK1-mediated necroptosis and skin inflammation.
    Kumari S; Van TM; Preukschat D; Schuenke H; Basic M; Bleich A; Klein U; Pasparakis M
    Life Sci Alliance; 2021 Jun; 4(6):. PubMed ID: 33858959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC activity is required for p65/RelA-dependent repression of PPARdelta-mediated transactivation in human keratinocytes.
    Aarenstrup L; Flindt EN; Otkjaer K; Kirkegaard M; Andersen JS; Kristiansen K
    J Invest Dermatol; 2008 May; 128(5):1095-106. PubMed ID: 18037904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia.
    Dajee M; Lazarov M; Zhang JY; Cai T; Green CL; Russell AJ; Marinkovich MP; Tao S; Lin Q; Kubo Y; Khavari PA
    Nature; 2003 Feb; 421(6923):639-43. PubMed ID: 12571598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense phosphorothioate oligonucleotides to NF-kappaB (RelA/NF-kappaB1) decrease interleukin-8 secretion from cultured normal human epidermal keratinocytes.
    Ikeda M; Hirose Y; Hamada R; Nakajima H; Miyoshi K; Matsumoto M; Seike M; Kodama H
    J Dermatol Sci; 2004 Sep; 35(3):230-2. PubMed ID: 15381247
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X; Kandasamy K; Srivastava RK
    Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB is required for UV-induced JNK activation via induction of PKCdelta.
    Liu J; Yang D; Minemoto Y; Leitges M; Rosner MR; Lin A
    Mol Cell; 2006 Feb; 21(4):467-80. PubMed ID: 16483929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition.
    Lind MH; Rozell B; Wallin RP; van Hogerlinden M; Ljunggren HG; Toftgård R; Sur I
    Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4972-7. PubMed ID: 15044707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NF-kappaB signaling interferes with phorbol ester-induced growth arrest of keratinocytes in a TNFR1-independent manner.
    Sur I; Ulvmar M; Jungedal R; Toftgård R
    J Recept Signal Transduct Res; 2009; 29(1):44-51. PubMed ID: 19519169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK4 regulation by TNFR1 and JNK is required for NF-kappaB-mediated epidermal growth control.
    Zhang JY; Tao S; Kimmel R; Khavari PA
    J Cell Biol; 2005 Feb; 168(4):561-6. PubMed ID: 15699216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
    Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timed NF-kappaB inhibition in skin reveals dual independent effects on development of HED/EDA and chronic inflammation.
    Ulvmar MH; Sur I; Mémet S; Toftgård R
    J Invest Dermatol; 2009 Nov; 129(11):2584-93. PubMed ID: 19516260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.
    Beg AA; Sha WC; Bronson RT; Ghosh S; Baltimore D
    Nature; 1995 Jul; 376(6536):167-70. PubMed ID: 7603567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype.
    Gapuzan ME; Yufit PV; Gilmore TD
    Oncogene; 2002 Apr; 21(16):2484-92. PubMed ID: 11971183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.